Machine learning assisted-nanomedicine using magnetic nanoparticles for central nervous system diseases-Reference-Cited by-同舟云学术

Machine learning assisted-nanomedicine using magnetic nanoparticles for central nervous system diseases

Published:2023 Issue:17 Volume:5 Page:4354-4367
ISSN:2516-0230
Container-title:Nanoscale Advances
language:en
Short-container-title:Nanoscale Adv.

Author:

Tomitaka Asahi¹^ORCID,Vashist Arti²³^ORCID,Kolishetti Nagesh²³^ORCID,Nair Madhavan²³^ORCID

Affiliation:

1. Department of Computer and Information Sciences, College of Natural and Applied Science, University of Houston-Victoria, Texas 77901, USA

2. Department of Immunology and Nano-Medicine, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida 33199, USA

3. Institute of NeuroImmune Pharmacology, Centre for Personalized Nanomedicine, Herbert Wertheim College of Medicine, Florida International University, Miami, Florida 33199, USA

Abstract

Machine learning allows the prediction of nanoparticles properties for various biomedical applications and disease detection using image classification. It has the potential to bridge the gap between basic research and clinical research.

Funder

Florida Department of Health

National Institute on Drug Abuse

Publisher

Royal Society of Chemistry (RSC)

Subject

General Engineering,General Materials Science,General Chemistry,Atomic and Molecular Physics, and Optics,Bioengineering

Link

http://pubs.rsc.org/en/content/articlepdf/2023/NA/D3NA00180F

Reference170 articles.

1. Applications of magnetic nanoparticles in biomedicine

2. Nanoscale Materials for Tackling Brain Cancer: Recent Progress and Outlook

3. Magnetic nanoparticle drug delivery systems for targeting tumor

4. Comprehensive understanding of magnetic hyperthermia for improving antitumor therapeutic efficacy

5. Tomographic imaging using the nonlinear response of magnetic particles

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug Delivery to the Brain: Recent Advances and Unmet Challenges;Pharmaceutics;2023-11-23